PreClinical CRO dedicated to your NonClinical projects
NEWS
Syncrosome at the 7th Microdialysis Symposium 2013 The Central Nervous System department is involved in Blood Brain barrier passage experiments since 10 years now. CSF sampling and Microdialysis are 2 important tools used to evaluate the kinetics of Candidate Compounds but also their action on the Neurotransmitters |
Syncrosome at the 2013 BioChicago Congress Richard Mitry, CEO of Syncrosome, attended the Biochicago Congress last month in United-States. |
Meet Syncrosome during Biotrinity congress As you know SYNCROSOME is a Preclinical Drug Evaluation Company specialised in human health. Since 2000, Syncrosome is mainly focused on in vivo efficacy studies dedicated to discovery and preclinical stage with more than 25 animals models, to provide you the right data to make the right decision. |
Animal models of Inflammatory Bowel Disease (IBD)? Inflammatory Bowel Disease (IBD) is a generic term that covers a range of disease including Ulcerative Colitis (UC) and Crohn's Disease (CD) for which there is still no cure. |
SYNCROSOME
Parc scientifique de Luminy
Case Postale 908
Luminy biotech entreprises
163, avenue de Luminy
13288 MARSEILLE cedex 09
France
Phone : +(33) 495 053 180
Web : www.syncrosome.com





Contact us: